Robert C. Lonergan
Président chez Brookwood Pharmaceuticals, Inc.
Profil
Robert C.
Lonergan is currently the Chairman at Brookwood Pharmaceuticals, Inc. and a Member-Advisory Board at The University of Alabama.
He was previously the President & Chief Executive Officer at Southern Research Institute, a Principal at General Electric Co., a Trustee at Underwriters Laboratories, Inc., and the President at Owens Corning.
He holds a graduate degree from Case Western Reserve University and an undergraduate degree from Georgetown University.
Postes actifs de Robert C. Lonergan
Sociétés | Poste | Début |
---|---|---|
Brookwood Pharmaceuticals, Inc.
Brookwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Surmodics, Inc., Brookwood Pharmaceuticals, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Birmingham, AL. Arthur J. Tipton has been the CEO of the company since 2005. Brookwood Pharmaceuticals was acquired by Surmodics, Inc. from Southern Research Institute on August 01, 2007 for $55.50 million. | Président | - |
The University of Alabama | Directeur/Membre du Conseil | - |
Anciens postes connus de Robert C. Lonergan
Sociétés | Poste | Fin |
---|---|---|
GE AEROSPACE | Corporate Officer/Principal | - |
Underwriters Laboratories, Inc.
Underwriters Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Underwriters Laboratories, Inc. engages in the provision of services for product safety certification. It offers certification, testing, inspection, auditing, validation, advisory and education services, bundles, software, and test tools. The company was founded by William Henry Merrill Jr. in 1894 and is headquartered in Northbrook, IL. | Directeur/Membre du Conseil | - |
OWENS CORNING | President | - |
Southern Research Institute
Southern Research Institute Miscellaneous Commercial ServicesCommercial Services Southern Research Institute is a scientific research organization. It focuses on research in drug discovery, drug development, energy and environment, and engineering. The firm serves pharmaceutical, biotechnology, defense, aerospace, environmental, and energy industries The company was founded in 1941 and is headquartered in Birmingham, AL. | President | - |
Formation de Robert C. Lonergan
Case Western Reserve University | Graduate Degree |
Georgetown University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
GE AEROSPACE | Producer Manufacturing |
OWENS CORNING | Process Industries |
Entreprise privées | 3 |
---|---|
Underwriters Laboratories, Inc.
Underwriters Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Underwriters Laboratories, Inc. engages in the provision of services for product safety certification. It offers certification, testing, inspection, auditing, validation, advisory and education services, bundles, software, and test tools. The company was founded by William Henry Merrill Jr. in 1894 and is headquartered in Northbrook, IL. | Commercial Services |
Southern Research Institute
Southern Research Institute Miscellaneous Commercial ServicesCommercial Services Southern Research Institute is a scientific research organization. It focuses on research in drug discovery, drug development, energy and environment, and engineering. The firm serves pharmaceutical, biotechnology, defense, aerospace, environmental, and energy industries The company was founded in 1941 and is headquartered in Birmingham, AL. | Commercial Services |
Brookwood Pharmaceuticals, Inc.
Brookwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Surmodics, Inc., Brookwood Pharmaceuticals, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Birmingham, AL. Arthur J. Tipton has been the CEO of the company since 2005. Brookwood Pharmaceuticals was acquired by Surmodics, Inc. from Southern Research Institute on August 01, 2007 for $55.50 million. | Health Technology |